DNA Sequencing Forges Ahead
Advances in DNA sequencing technology are making applications of whole-genome sequencing a reality
Advances in DNA sequencing technology are making applications of whole-genome sequencing a reality
The race is on to sequence whole genomes for $1,000, but already companies are talking about shattering that mark and making scans no more expense than routine procedures such as blood and urine testsÉ
The Bay Area flexed its innovation muscles Thursday, with local companies winning 12 of the 26 Technology Pioneers Awards handed out by the World Economic ForumÉ
Want to know which company will be the next Google? It could be Metabolix, a company from Cambridge, Mass., that grows biodegradable plastic in plant. Or British company Playfish, which creates addictive videogames…
Innovation in the trillion-dollar-per-year construction industry has been pretty sluggish over the past century. The low-tech method for producing standard gypsum drywall, for instance, was invented in 1917
Nine Silicon Valley companies were honored as technology pioneers by the World Economic Forum, an international nonprofit focused on entrepreneurship in the global public interestÉ
Pacific Biosciences this week revealed a number of performance specifications for its first commercial single-molecule real-time DNA sequencer, due to be released during the second half of 2010, as well as a roadmap for…
Semiconductor developments during the last five decades or so have transformed the electronics industry beyond recognition. Now, the amazing techniques developed by semiconductor manufacturers are doing something similar for an entirely differentÉ
The National Human Genome Research Institute (NHGRI) has awarded more than $113 million provided by the American Recovery and Reinvestment Act. The new awards, added to NHGRI’s regularly appropriated $367 million budget, willÉ
During a six-year stint as head of cancer research at Merck, genetics entrepreneur Stephen Friend tried to inject a new kind of biology, synthesized from supercomputers and reams of biological data, into a staid drug maker as it
Stephen Turner being interviewed on Forbes
The firm disclosed that it is collaborating with six early-access customers, including Monsanto and the Scripps Institute, on a variety of sequencing projects. It will soon finalize the list of institutions that will receive…
Earlier this year, Pacific Biosciences founder and CTO Stephen Turner ran an animation of a real-time single-molecule sequence trace as a crawl at the foot of his slides for the duration of his talk, demonstratingÉ
Steve Turner’s DNA scanner is radically different from any other company’s approachÉ
For over a decade, Eric Schadt has been one of a handful of scientists blending mathematics, biology and supercomputers to pursue a new understanding of human biology,É
If you have a question, need to check the status of an order, or are interested in purchasing an instrument, we're here to help.